Vaxart Inc. (NASDAQ: VXRT) stock fell -7.86% on Wednesday to $1.29 against a previous-day closing price of $1.40. With 2.01 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.55 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $1.4400 whereas the lowest price it dropped to was $1.2800. The 52-week range on VXRT shows that it touched its highest point at $4.61 and its lowest point at $0.56 during that stretch. It currently has a 1-year price target of $6.12. Beta for the stock currently stands at 0.73.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of VXRT was down-trending over the past week, with a drop of -5.49%, but this was up by 75.99% over a month. Three-month performance surged to 47.23% while six-month performance fell -3.73%. The stock lost -61.72% in the past year, while it has gained 34.25% so far this year. A look at the trailing 12-month EPS for VXRT yields -0.83 with Next year EPS estimates of -0.70. For the next quarter, that number is -0.18. This implies an EPS growth rate of -45.50% for this year and 8.60% for next year.
Float and Shares Shorts:
At present, 135.21 million VXRT shares are outstanding with a float of 130.15 million shares on hand for trading. On May 14, 2023, short shares totaled 18.71 million, which was 13.80% higher than short shares on Apr 13, 2023. In addition to Mr. Cezar Andrei Floroiu M.B.A. as the firm’s CEO, Pres & Director, Dr. Sean N. Tucker Ph.D. serves as its Sr. VP & Chief Scientific Officer.
Through their ownership of 33.21% of VXRT’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 2.07% of VXRT, in contrast to 14.16% held by mutual funds. Shares owned by individuals account for 11.13%. As the largest shareholder in VXRT with 5.80% of the stake, BlackRock Fund Advisors holds 7,861,951 shares worth 7,861,951. A second-largest stockholder of VXRT, The Vanguard Group, Inc., holds 6,926,711 shares, controlling over 5.11% of the firm’s shares. Geode Capital Management LLC is the third largest shareholder in VXRT, holding 2,662,473 shares or 1.96% stake. With a 3.00% stake in VXRT, the Vanguard Total Stock Market ETF is the largest stakeholder. A total of 4,069,328 shares are owned by the mutual fund manager. The iShares Russell 2000 ETF, which owns about 2.06% of VXRT stock, is the second-largest Mutual Fund holder. It holds 2,786,533 shares valued at 2.27 million. Vanguard Extended Market Index Fu holds 1.32% of the stake in VXRT, owning 1,792,995 shares worth 1.46 million.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Mar 30, 2023, VXRT reported revenue of $0.00 and operating income of -$29.25M. The EBITDA in the recently reported quarter was -$27.87M and diluted EPS was -$0.23.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for VXRT since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With VXRT analysts setting a high price target of $10.00 and a low target of $1.50, the average target price over the next 12 months is $5.83. Based on these targets, VXRT could surge 675.19% to reach the target high and rise by 16.28% to reach the target low. Reaching the average price target will result in a growth of 351.94% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
Summary of Insider Activity:
Insiders traded VXRT stock several times over the past three months with 15 Buys and 0 Sells. In these transactions, 1,130,500 shares were bought while 0 shares were sold. The number of buy transactions has increased to 27 while that of sell transactions has risen to 3 over the past year. The total number of shares bought during that period was 1,315,707 while 26,240 shares were sold.